Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis

JAMA ◽  
2021 ◽  
Vol 326 (20) ◽  
pp. 2021
Author(s):  
Kim L. Bennell ◽  
Kade L. Paterson ◽  
Ben R. Metcalf ◽  
Vicky Duong ◽  
Jillian Eyles ◽  
...  
2011 ◽  
Vol 70 (10) ◽  
pp. 1770-1774 ◽  
Author(s):  
Kim L Bennell ◽  
Kelly-Ann Bowles ◽  
Yuanyuan Wang ◽  
Flavia Cicuttini ◽  
Miranda Davies-Tuck ◽  
...  

ObjectiveMechanical factors, in particular increased medial knee joint load, are believed to be important in the structural progression of knee osteoarthritis. This study evaluated the relationship of medial knee load during walking to indices of structural disease progression, measured on MRI, in people with medial knee osteoarthritis.MethodsA longitudinal cohort design utilising a subset of participants (n=144, 72%) enrolled in a randomised controlled trial of lateral wedge insoles was employed. Medial knee load parameters including the peak knee adduction moment (KAM) and the KAM impulse were measured at baseline using three-dimensional gait analysis during walking. MRI at baseline and at 12 months was used to assess structural indices. Multiple regression with adjustment for covariates assessed the relationship between medial knee load parameters and the annual change in medial tibial cartilage volume. Binary logistic regression was used for the dichotomous variables of progression of medial tibiofemoral cartilage defects and bone marrow lesions (BML).ResultsA higher KAM impulse, but not peak KAM, at baseline was independently associated with greater loss of medial tibial cartilage volume over 12 months (β=29.9, 95% CI 6.3 to 53.5, p=0.01). No significant relationships were seen between medial knee load parameters and the progression of medial tibiofemoral cartilage defects or BML.ConclusionThis study suggests knee loading, in particular the KAM impulse, may be a risk factor for loss of medial tibial cartilage volume. As knee load is modifiable, load-modifying treatments may potentially slow disease progression.


2010 ◽  
Vol 12 (2) ◽  
pp. R58 ◽  
Author(s):  
Stephanie K Tanamas ◽  
Anita E Wluka ◽  
Jean-Pierre Pelletier ◽  
Johanne Martel-Pelletier ◽  
François Abram ◽  
...  

JAMA ◽  
2016 ◽  
Vol 315 (10) ◽  
pp. 1005 ◽  
Author(s):  
Xingzhong Jin ◽  
Graeme Jones ◽  
Flavia Cicuttini ◽  
Anita Wluka ◽  
Zhaohua Zhu ◽  
...  

2009 ◽  
Vol 17 (1) ◽  
pp. 8-11 ◽  
Author(s):  
A.J. Teichtahl ◽  
M.L. Davies-Tuck ◽  
A.E. Wluka ◽  
G. Jones ◽  
F.M. Cicuttini

2017 ◽  
Vol 35 (11) ◽  
pp. 2476-2483 ◽  
Author(s):  
Nicholas M. Brisson ◽  
Emily G. Wiebenga ◽  
Paul W. Stratford ◽  
Karen A. Beattie ◽  
Saara Totterman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document